Cargando…
Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804479/ http://dx.doi.org/10.1016/j.jaci.2021.12.240 |
| _version_ | 1784643081209905152 |
|---|---|
| author | Doss, Alexa Chen, Rita Monroy, Jennifer Wedner, H. James Kulczycki, Anthony Dy, Tiffany Ren, Zhen Kau, Andrew Mantia, Tarisa O'Shaughnessy, Caitlin Nickles, Brandi Kendall, Peggy Diamond, Michael Zimmerman, Ofer |
| author_facet | Doss, Alexa Chen, Rita Monroy, Jennifer Wedner, H. James Kulczycki, Anthony Dy, Tiffany Ren, Zhen Kau, Andrew Mantia, Tarisa O'Shaughnessy, Caitlin Nickles, Brandi Kendall, Peggy Diamond, Michael Zimmerman, Ofer |
| author_sort | Doss, Alexa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8804479 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88044792022-02-01 Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination Doss, Alexa Chen, Rita Monroy, Jennifer Wedner, H. James Kulczycki, Anthony Dy, Tiffany Ren, Zhen Kau, Andrew Mantia, Tarisa O'Shaughnessy, Caitlin Nickles, Brandi Kendall, Peggy Diamond, Michael Zimmerman, Ofer J Allergy Clin Immunol Article Published by Mosby, Inc. 2022-02 2022-02-01 /pmc/articles/PMC8804479/ http://dx.doi.org/10.1016/j.jaci.2021.12.240 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Doss, Alexa Chen, Rita Monroy, Jennifer Wedner, H. James Kulczycki, Anthony Dy, Tiffany Ren, Zhen Kau, Andrew Mantia, Tarisa O'Shaughnessy, Caitlin Nickles, Brandi Kendall, Peggy Diamond, Michael Zimmerman, Ofer Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination |
| title | Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination |
| title_full | Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination |
| title_fullStr | Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination |
| title_full_unstemmed | Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination |
| title_short | Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination |
| title_sort | patients with primary antibody deficiency syndromes show attenuated neutralizing activity of sars-cov-2 following covid-19 vaccination |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804479/ http://dx.doi.org/10.1016/j.jaci.2021.12.240 |
| work_keys_str_mv | AT dossalexa patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT chenrita patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT monroyjennifer patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT wednerhjames patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT kulczyckianthony patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT dytiffany patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT renzhen patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT kauandrew patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT mantiatarisa patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT oshaughnessycaitlin patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT nicklesbrandi patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT kendallpeggy patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT diamondmichael patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination AT zimmermanofer patientswithprimaryantibodydeficiencysyndromesshowattenuatedneutralizingactivityofsarscov2followingcovid19vaccination |